Absstract of: US20260265785A1
The present invention deals with a need in the field of sustainability and involves a sustainable alternative for the improvement of air quality, and with an emphasis on the capture of carbon dioxide and carbon monoxide using aquatic organisms, microalgae and cyan bacteria.
Absstract of: US20260265101A1
The present invention discloses a process mode of microalgal cultivation in semi-continuous on wine wastewater with no need to recirculate the microalgal biomass in the reactor, without dilution and sterilisation of the effluent applied as a growth medium. The process was experimentally carried out by semi-continuously applying, without recirculation of the biomass, the cultivation of Chlorella vulgaris on the digestate from the anaerobic co-digestion of winemaking lees and waste activated sludge. The integrated anaerobic digestion-microalgae treatment process is advantageous from a circular economy perspective as it leads to the exploitation of grape processing chain waste, eliminating the economic burden on producers and involving: i) the phyto-depuration of the effluent, ii) the production of bio-methane and iii) the production of biomass containing high value-added by-products (lipids, proteins and starch) that can be used to produce biodiesel, animal feed, nutraceuticals/pharmaceuticals and for producing bioplastics.
Absstract of: AU2026220199A1
Abstract Provided are compositions containing extracellular vesicles from microalgae (MEVs) that are exogenously loaded with bioactive cargo or other cargo of interest, such as for therapeutic, industrial, diagnostic, and cosmetic uses. The MEVs have a variety of applications as therapeutics, including as vaccines, as anti-cancer therapeutics, as diagnostics, and other such uses Abstract
Absstract of: EP4803075A1
0001 Provided are compositions and drug delivery systems containing extracellular vesicles from microalgae (MEVs) that are loaded with bioactive cargo. The MEVs are formulated and administered by a variety of routes of administration and have a variety of applications as therapeutics, including as vaccines, as anti-cancer therapeutics, as therapeutics for psychiatric diseases, disorders, and conditions as diagnostics, and other such uses.
Absstract of: EP4803603A1
La présente invention concerne un photobioréacteur (10) comprenant une cuve de culture (20) adaptée à recevoir une culture de microalgues.La cuve de culture (20) est équipée de moyens d'agitation (40), immergés, comprenant un rotor (41).Ce rotor (41) comprend un moyeu (411) qui est destiné à être raccordé à une alimentation (50) en flux d'air et qui est prolongé par au moins un bras radial tubulaire (412) sur lequel sont répartis des orifices de bullage (4121) pour la libération dudit flux d'air.Et au moins une partie de la longueur dudit au moins un bras radial tubulaire (412) épouse ladite paroi de fond (21) de sorte qu'une première cote en distance (L1) entre l'un au moins desdits orifices de bullage (4121) et ladite paroi de fond (21) est égale ou inférieure à 50 mm, de préférence de 5 mm à 20 mm.
Absstract of: WO2026181093A1
Components of oily sludge contaminate the environment, disrupt the endocrine system, and are carcinogenic. Proper and complete treatment of the oily sludge followed by its safe disposal is essential to minimize environmental impact and protect human health. Existing treatment methods for oily sludge include incineration, landfilling, pyrolysis, and supercritical water oxidation; however, these techniques are energy-intensive, costly, and pose higher risks of environmental pollution. The present invention discloses a novel process for oily sludge degradation using a mild hydrothermal-assisted microalgae-based phycoremediation strategy. The method achieves 70– 75% degradation of long-chain aromatic and aliphatic hydrocarbons within 4–6 weeks. The degradation efficiency may further increase when the treatment period exceeds 6 weeks. Compared with conventional energy-intensive technologies for oil sludge treatment, the proposed method is more economical, environmentally sustainable, and suitable for long-term scale-up, with added potential for revenue generation.
Absstract of: WO2026177421A1
The present invention relates to: a method for preparing a highly functional DNA fragment mixture derived from microorganisms (yeast, microalgae, lactic acid bacteria, and the like); and a functional composition comprising a DNA fragment mixture prepared thereby. Specifically, the present invention relates to the preparation of a DNA fragment mixture having a uniform size within a certain range by using a specific restriction enzyme in microorganisms (yeast, microalgae, lactic acid bacteria, and the like). According to the present invention, a functional composition may be provided, which comprises the DNA fragment mixture as a main ingredient, and exhibits excellent effects in filling an interstitial scaffold, improving skin condition, regenerating tissue, healing wounds, moisturizing, promoting ECM synthesis, inhibiting cellular senescence, forming new blood vessels, alleviating inflammation, relieving pain, treating dermatitis such as atopy, inhibiting hair loss, promoting hair growth, and promoting stem cell activity.
Absstract of: KR20260129263A
본 발명은 미세조류를 이용한 퍼플루오로옥탄산의 제거 방법에 관한 것이다. 본 발명자들은 미세조류를 이용하여 친환경적으로 퍼플루오로옥탄산(perfluorooctanoic acid, PFOA)을 제거하고 오염된 미세조류를 바이오매스로 활용하기 위한 방법을 개발하고자 예의 연구 노력하였다. 본 발명의 S. quadricauda을 이용한 퍼플루오로옥탄산(PFOA)의 제거방법 및 바이오디젤 생산 방법을 이용하는 경우, PFOA를 효과적으로 제거하고 기존 PFOA 제거 방식이 갖던 한계점을 극복할 수 있으며, PFOA 제거 후 오염된 S. quadricauda을 이용하여 바이오디젤 생산 효율을 증진시킬 수 있으므로 산업상 활용 가치가 높다고 판단된다.
Absstract of: WO2026173382A1
The present disclosure relates to a method for producing biomass, which enables economical production of microalgae biomass having a high solid content and low viscosity.
Absstract of: WO2026173381A1
The present disclosure relates to a method for producing a biomass, and a biomass having high solid content can be economically produced thereby.
Absstract of: US20260234544A1
This microorganism belongs to the genus Rhodococcus, Xanthobacter, Ancylobacter, Shewanella, or Aeromonas. Said microorganism may be Rhodococcus cerastii belonging to the genus Rhodococcus, Xanthobacter flavus belonging to the genus Xanthobacter, or Ancylobacter rudongensis belonging to the genus Ancylobacter. Said microorganism may be for promoting the growth of cyanobacterium, green algae, glaucophyte algae, or Euglena algae. Said microorganism may be for promoting the growth of organisms belonging to the phylum Cyanobacteria, Ochrophyta, Euglena, Cryptophyta, Haptophyta, Cercozoa, Glaucophyta, Rhodophyta, Chlorophyta, or Streptophyta.
Absstract of: EP4790127A1
A system and method are provided for processing an industrial effluent and cultivating microalgae. The system comprises a primary tank, a screening unit with a motor-driven cleaning mechanism, a flocculation tank supplied with a chemical flocculant, a sand filter, an acidification unit with pH control, a solid-liquid separation unit, an anaerobic digestion unit, and a microalga cultivation unit. The effluent is screened, flocculated, filtered, acidified to a pH from 4.2 to 5.2, preferably 4.45 to 4.75, and subjected to solid-liquid separation to remove precipitated proteins and destabilised colloidal material, thereby producing a clarified effluent. The clarified effluent is anaerobically digested at a defined organic loading rate to generate biogas and a liquid digestate. At least a portion of the digestate and/or carbon dioxide derived from the biogas is used for microalga cultivation. The system enables stable anaerobic digestion without membrane-based pretreatment and provides a conditioned stream suitable for downstream microalga growth.
Absstract of: EP4790131A1
A process for producing calcium hydroxide, comprising:reacting calcium carbonate with an acid in an aqueous solution at a temperature of 10-50°C to produce a calcium ion solution and carbon dioxide,separating the carbon dioxide from the calcium ion solution,treating the calcium ion solution to form calcium hydroxide,directing the separated carbon dioxide to a photobioreactor containing microalgae, andgrowing the microalgae in the photobioreactor using the carbon dioxide through photosynthesis.
Absstract of: US20260226398A1
The invention relates to an algae biomass having particular values within a defined colour space. The invention further relates to a strain of Chlorella microalgae having a genetic mutation in genes encoding for specific subunits of magnesium chelatase, preferably magnesium chelatase subunit, and also relates to a method of producing a strain of Chlorella microalgae having such mutations.
Absstract of: US20260223795A1
0000 Microalgae are grown in a biofilm on carriers. In some examples, the carriers are surfaces with a small angle to the vertical. Optionally, the carriers may have surfaces on both sides of a vertical plane (e.g., an inverted V) or surrounding a vertical axis (e.g., a cone). In some examples, the carriers include two or more sheets of a porous material such as a fabric, screen or mesh. In some examples a surface of the carrier is flexible. In some examples, the carriers provide a specific surface area for algae growth greater than 7 m<2>/m<2>.
Absstract of: WO2026163125A1
The present invention relates to a symbiotic therapeutic technique based on a genetically modified eukaryotic microalga (51), preferably photosynthetic, such as for example Chlamydomonas reinhardtii, in which an expression cassette (10) codifying a biologically active peptide and/or protein comprises a secretion coding module (5) of a therapeutic agent to allow the biologically active peptide/protein to be released so that it can cross the cell wall of the microalga (51), to be secreted outside of it and enter directly into the circulation in a subject (53) in which said genetically modified eukaryotic microalga (51) has been subcutaneously or intradermally injected. The microalga can be of a type that naturally: a) lacks flagella; or b) has flagella, in which case a prior genetic modification prevents the formation or inactivates the flagella, so that the microalga remains immobilised at a subject injection site (53). The expression cassette (10) can further comprise at least one further coding module selected from: a homing module (6), for targeting the peptide/protein to a predetermined tissue and/or cell population of the subject (53); a penetrating module (7) for inducing internalisation of the protein within a cell of said subject (53) through the cell membrane or by induced endocytosis; a protection module (9). The invention also relates to a subcutaneously or intradermally injectable composition containing said microalgae, and to a kit for preparing said composition.
Absstract of: EP4785810A1
0001 An object of the present invention is to provide a formulation effective for maintaining or increasing hair fibrous structural proteins. Provided are a composition for maintaining or increasing fibrous structural proteins, a composition for maintaining or increasing skin elasticity, a composition for improving hair quality, and a composition for promoting production of collagen, elastin, or hyaluronic acid, which contain a culture supernatant and/or extracellular vesicles of a microalga.
Absstract of: KR20260118887A
본 발명은 미세조류 배양기의 배양 수조에 물을 공급하여 충진하는 물 공급 단계와, 상기 배양 수조로 오존을 공급하는 오존 공급 단계와, 상기 배양 수조에 과초산을 공급하는 과초산 공급 단계와, 상기 배양 수조의 내부에 형성된 상기 물과 오존 및 과초산을 포함하는 복합 세척액에 공기 기포를 공급하는 배양 수조 세척 단계와, 상기 배양 수조에 오존 중화제를 공급하는 오존 중화제 공급 단계 및 상기 배양 수조에 수용되어 있는 세척 혼합물을 필터링하는 세척 혼합물 필터링 단계를 포함하는 미세조류 배양기 세척 방법을 개시한다.
Absstract of: US20260218259A1
0000 Provided are a biological flocculant, a preparation method therefor and use thereof in control of Cyanobacteria. The biological flocculant includes cationic hydroxyethyl cellulose and an extracellular polysaccharide. The extracellular polysaccharide is produced by fermentation of Agrobacterium sp. LHZJX.A07 that is taxonomically named. A method for preparing the extracellular polysaccharide includes screening Agrobacterium from a soil enrichment culture dilution spread plate, purifying and inoculating the Agrobacterium into a culture medium for culture, performing fermentation to obtain a extracellular polysaccharide crude solution, and performing concentration, purification and drying to obtain the extracellular polysaccharide.
Absstract of: US20260218421A1
0000 A process is described for preparing a microfibre with living microalgae inside, including the steps of: preparing and mixing micro-algae and a biomaterial in a nutritional medium; and micro-fluidic spinning of the micro-algae mixture and the biomaterial which is polymerized; wherein the micro-fluidic spinning is carried out in a micro-fluidic spinning chip, provided with a spinning die having a “grooves” section, so as to obtain a grooved section.
Absstract of: US20260218211A1
0000 The present disclosure relates to recombinant cyanobacterial cells for the production of a chemical compound of interest. In particular, the present disclosure relates to genetic modifications that introduce one or more heterologous polyketide synthases (PKS) into a cyanobacterial cell. These cells can further comprise nucleic acid constructs that provide the cyanobacterial cells with the capability of producing chemicals of interest or compounds of interest, including Compound (I).
Absstract of: US20260209683A1
0000 The invention provides marine microalgal strain of the Ulvales order of the Ulvophyceae class which have utility in the efficient and environmentally beneficial preparation of triacylglycerides and polyunsaturated fatty acids, which can in turn be used for fuels or feeds.
Absstract of: AU2025209239A1
The invention relates to the production of a novel food product made from one or more microalgae. It can be used as an intermediate for manufacturing a more complex product intended either for human food or for veterinary food. The invention also relates to the uses of said food product made from one or more microalgae. The invention also relates to a method for producing said food product made from one or more microalgae.
Absstract of: CN122428024A
The invention relates to a high-sensitivity and high-efficiency method for detecting the number of gametes of noctiluca, which comprises the following steps: filtering a water sample to be detected, collecting microalgae cells, and extracting by adopting a Chelex-100 chelation method to obtain a DNA (Deoxyribose Nucleic Acid) template; a ddPCR reaction system is constructed, the ddPCR reaction system comprises the DNA template, a specific primer pair and a TaqMan probe, the sequence of the specific primer pair is an Ns175F primer as shown in SEQ ID NO.1 and an Ns268R primer as shown in SEQ ID NO.2, the sequence of the TaqMan probe is as shown in SEQ ID NO.3, the 5'end of the probe is labeled with a fluorescence reporter group, and the 3 'end of the probe is labeled with a fluorescence quenching group; carrying out PCR amplification on the ddPCR reaction system after the ddPCR reaction system is subjected to microdroplet segmentation; reading a fluorescence signal of a PCR amplification product, calculating the initial concentration of the target DNA according to the positive microdroplet proportion, and converting to obtain the concentration of the gametes of the noctiluca in the water sample to be detected. The method can solve the problems of low detection sensitivity, complicated operation and inaccurate quantification of low-abundance samples in the prior art.
Nº publicación: CN122423508A 21/07/2026
Applicant:
PINGSHAN JIUXU ECOLOGICAL BREEDING CO LTD
\u5E73\u5C71\u53BF\u4E5D\u65ED\u751F\u6001\u517B\u6B96\u6709\u9650\u516C\u53F8
Absstract of: CN122423508A
A milch goat feeding method relates to the technical field of feeding, the milch goat feeding method comprises the following steps: feeding fodder including coarse fodder, concentrated fodder and a selenium preparation, adding the coarse fodder and the concentrated fodder according to four seasons in the growth period and the recovery period of milch goats for conventional feeding, and reducing the coarse fodder, increasing the concentrated fodder and adding the selenium preparation in the pregnancy period and the milk production period; the concentrated feed comprises corn, soybean meal, bran and trace elements, the trace elements comprise multivitamins, salts and a calcium preparation, the selenium preparation is a fresh microalgae wet material rich in organic selenium, and the calcium preparation comprises one or more of calcium hydrophosphate, bone meal and soybean curb residues. The milch goats are fed with compound feed composed of coarse feed, concentrated feed and selenium-rich fresh microalgae, and fresh goat milk rich in organic selenium and calcium is obtained.